Cargando…
Experiences of healthcare and substance use treatment provider-based stigma among patients receiving methadone
BACKGROUND: Medications for Opioid Use Disorder (MOUD) are efficacious, however only one-third of individuals with an opioid use disorder (OUD) enter into treatment. Low rates of MOUD utilization are partially due to stigma. This study examines provider-based stigma toward MOUD and identifies factor...
Autores principales: | Carl, Alexis, Pasman, Emily, Broman, Michael J., Lister, Jamey J., Agius, Elizabeth, Resko, Stella M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10040326/ https://www.ncbi.nlm.nih.gov/pubmed/36994374 http://dx.doi.org/10.1016/j.dadr.2023.100138 |
Ejemplares similares
-
Cumulative barriers to retention in methadone treatment among adults from rural and small urban communities
por: Pasman, Emily, et al.
Publicado: (2022) -
Comorbid Affective and Substance Use Disorders of Medicaid/Medicare Beneficiaries at an Opioid Treatment Program Serving Small Urban and Rural Communities
por: Lister, Jamey J., et al.
Publicado: (2022) -
Risk-factors for methadone-specific deaths in Scotland’s methadone-prescription clients between 2009 and 2013*
por: Gao, Lu, et al.
Publicado: (2016) -
Examining stigma relating to substance use and contextual factors in social media discussions
por: Chen, Annie T., et al.
Publicado: (2022) -
Implementation opportunities for scaling up methadone maintenance treatment in Kyrgyzstan: Methadone dosage and retention on treatment over two years
por: Ivasiy, Roman, et al.
Publicado: (2022)